(SYNH) – Company Press Releases
-
NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
-
Syneos Health Closes Transaction with Private Investment Firms
-
Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600
-
Syneos Health Names Terttu Haring President, Clinical Sites & Patients
-
SYNH DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action – SYNH
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Syneos, Lordstown, and Aldeyra and Encourages Investors to Contact the Firm
-
Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Danaher, Sea, and Syneos and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sea, Syneos, and Lordstown and Encourages Investors to Contact the Firm
-
Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured Notes
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Danaher, Sea, and Syneos and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sea, Syneos, and Lordstown and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Danaher, and Syneos and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Danaher, and Syneos and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, Danaher, and Syneos and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Syneos, AT&T, RTX, and Eos and Encourages Investors to Contact the Firm
-
Syneos Health Stockholders Approve Agreement with Private Investment Consortium
-
Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health
-
Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
-
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
-
Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
-
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health
-
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
-
Syneos Health Leaders Recognized by HBA
-
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
-
Syneos Health Reports First Quarter 2023 Results
-
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
-
Syneos Health Appoints Michael Bonello as Chief Financial Officer
-
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
-
Syneos Health Wins 2023 ViE Award
-
Syneos Health Names Jeanine O’Kane as Communications President
-
Syneos Health Launches Medical Affairs Digital Amplifier
-
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
-
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
-
Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201
-
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
-
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
-
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
-
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
-
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
-
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
-
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
-
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
-
Syneos Health Announces Chief Financial Officer Transition
-
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Syneos Health Extends Partnership with Medable
-
Tetris Pharma signs service agreement with Syneos Health
-
Syneos Health Releases 2023 Health Trends
-
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
-
Syneos Health Reports Third Quarter 2022 Results
Back to SYNH Stock Lookup